Diabetes

The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

AJMC
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021

July 31st 2025

Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.

PFAS | Image credit: Vodkaz - stock.adobe.com
PFAS Exposure Linked to Increased Risk of Type 2 Diabetes, Study Finds

July 29th 2025

Diabetes monitoring | Image credit: abidika - stock.adobe.com
SGLT2i-Induced Erythrocytosis Not Linked to Clots in Type 2 Diabetes

July 21st 2025

MRI head brain scan - DedMityay - stock.adobe.com
Semaglutide, Tirzepatide Cut Dementia, Stroke Risk in Type 2 Diabetes

July 18th 2025

Doctor examines eye anatomy model using magnifying glass | Image credit: Viktor - stock.adobe.com
Clinical Data Predicts Risk of Progression to Proliferative Diabetic Retinopathy

July 15th 2025

Advancing Care in Type 2 Diabetes and Obesity: A Coordinated, Guideline-Driven Approach

Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.

AJMC Peer Exchange geometric background
Continuing Medical Education
View All
July 31st 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
July 31st 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Site Logo
September 14th 2022

Pharmaceutical Care Services for Patients With Diabetes: A Systematic Scoping Review

Ramzi Shawahna, PhD Farah Thawabi, PharmD Rahaf Salah, PharmD Sally Ramadan, PharmD
Major databases were systematically searched for articles reporting on pharmaceutical care services for patients with diabetes, and 86 pharmaceutical care services were qualitatively synthesized.
Link Between T2D Complications, Sleep Disorders Found in Mexican Americans
September 12th 2022

Link Between T2D Complications, Sleep Disorders Found in Mexican Americans

Julia Bonavitacola
A recent study found a potential relationship between type 2 diabetes (T2D) macro- and microvascular complications and increased risk of sleep disorders in older Mexican Americans.
City
September 10th 2022

Diabetes-Related Mortality Rates Decrease in Urban Areas, Remain Stagnant in Rural

Julia Bonavitacola
A new study has found that diabetes-related deaths in rural areas did not decrease for the period of 1999 to 2019, tripling the mortality gap between urban and rural patients with diabetes.
Vegetables, fish, and chicken
September 6th 2022

Reduced Processed Red Meat Consumption May Lower Diabetes Risk

Julia Bonavitacola
A prospective cohort study found that women who replaced processed red meat with fatty fish, unprocessed red meat, or vegetables had reduced risks of hypertension and diabetes.
Two people walking
August 31st 2022

People Who Accumulate More Steps per Day Have Lower Risk of Diabetes

Julia Bonavitacola
A population-based cohort study of Hispanic Americans found that people who walked more per day had a lower risk of being diagnosed with type 2 diabetes.
image of woman in CBT session
August 29th 2022

Review Examines Traditional, Newer Forms of CBT on Diabetes-Related Distress

Allison Inserro
While cognitive behavioral therapy (CBT) is known to be effective for generalized depression and anxiety, it is only recently that research has begun exploring its specific use in diabetes, including looking at the effects on depression, anxiety, and glycemic control.
What We're Reading
August 25th 2022

What We’re Reading: Amazon Care to Shut Down; Rise in Youth T2D Diagnoses; Revealing Pressure on FDA Authorization Decisions

AJMC Staff
Amazon will shut down its telehealth venture Amazon Care by the end of 2022; youth type 2 diabetes (T2D) diagnoses rose by 77% in the first year of the COVID-19 pandemic; officials during Donald Trump’s presidency tried to push for the FDA reauthorization of a discredited COVID-19 treatment.
Insulin
August 24th 2022

Self-management Vital for Patients With Diabetes Who Have Intellectual Disabilities

Julia Bonavitacola
According to this systematic review, the best way to optimize diabetes management for patients with both diabetes and intellectual disabilities is supported self-management, which has numerous obstacles to full implementation.
graphic depicting health care costs
August 21st 2022

Health Care Utilization Study Compares Costs of Empagliflozin, DPP-4 Inhibitors, and GLP-1 Agonists for T2D

Rose McNulty
The results suggest that dipeptidyl peptidase-4 (DDP-4) inhibitors, which are widely prescribed in Germany, are not a cost-effective option despite lower drug pricing compared with empagliflozin.
Blood cells
August 14th 2022

Biomarker Linked With Risk of Diabetes, Cancer Deaths

Julia Bonavitacola
A cross-sectional association was found between plasma prostasin level and risk of diabetes and cancer mortality in patients with high blood glucose levels.
Paul Hahn, MD
August 12th 2022

Dr Paul Hahn on the Importance of Understanding the Economic Value of DME Treatments

For vision-threatening diseases, such as diabetic macular edema (DME) understanding the economic value of treatments can help identify the direct and indirect benefits of different treatments, said Paul Hahn, MD, vitreoretinal surgeon at NJRetina.
Site Logo
August 9th 2022

Activation, Physical Activity, and Outcomes Among Individuals With T2D

Radhika Nair, PhD Eric Meadows, PhD Richard Sheer, BA Ilya Lipkovich, PhD Jiat-Ling Poon, PhD Zhenxiang Zhao, PhD Brian Benneyworth, MD Margaret Pasquale, PhD
This study presents an integrated, exploratory assessment of physical activity, patient activation, health-related quality of life, and clinical outcomes among older adults with type 2 diabetes (T2D) using survey, wellness, and claims data.
capsule bursting open with change
August 8th 2022

Budget Bill Allowing Medicare to Negotiate Drug Prices Heads to House

Allison Inserro
HR 5376, or the Inflation Reduction Act, is most significant piece of legislation affecting federal health policy since the passage of the Affordable Care Act in 2010; for Medicare beneficiaries, it caps insulin at $35 a month and includes other pricing reforms.
Cardiologists Must “Get Into the Game” With Novel Agents in Patients With Diabetes
August 3rd 2022

Cardiologists Must “Get Into the Game” With Novel Agents in Patients With Diabetes

Mary Caffrey
During the 2022 Congress of the American Society for Preventive Cardiology (ASPC), held in Louisville, Kentucky, Erin D. Michos, MD, MHS, of Johns Hopkins, and Pam R. Taub, MD, of UC San Diego Health, discussed how treatment of diabetes requires going beyond glucose-lowering therapies and including newer medications that offer cardiovascular benefits.
a picture of healthy food
July 29th 2022

Time-Restricted Eating Improves Glucose Control for Patients With Type 2 Diabetes

Lindsey Mulrooney
Following a time-restricted eating schedule, limited to a 10-hour window, provides beneficial metabolic effects and the potential for weight loss in patients with type 2 diabetes, according to a new study.
Annual Wellness Visits Reduce Likelihood of Amputation for Patients With Diabetes
July 23rd 2022

Annual Wellness Visits Reduce Likelihood of Amputation for Patients With Diabetes

Lindsey Mulrooney
Researchers suggest that annual wellness visits for patients with diabetes lead to earlier diagnoses of complications, preventing amputations and serious consequences.
Doctor speaking to patient
July 19th 2022

Modifiable Factors Affect Treatment Adherence in Patients With T2D

Julia Bonavitacola
A recent review found that there were several modifiable and nonmodifiable factors that can affect the treatment adherence of patients with type 2 diabetes (T2D).
diabetes
July 15th 2022

Risk of T2D From Corticosteroid Exposure Associated With Age, Sex, BMI, Steroid Dose

Lindsey Mulrooney
A recent study characterized the known association between corticosteroid exposure and type 2 diabetes (T2D), finding risk to be associated with treatment- and patient-related characteristics that can inform prescription of treatment with steroids.
image of healthy food
July 13th 2022

Diabetes Prevention Programs Go Unused Even as Prediabetes Soars

Lindsey Mulrooney
Although prediabetes prevalence jumped 4.8 percentage points from 2010 to 2020, barriers to accessing diabetes prevention interventions persist, driven by cost, eligibility requirements, and data integration, leading to low participation rates.
What We're Reading
July 8th 2022

What We’re Reading: Order on Abortion Medicine, Emergency Contraception; California and Insulin; CMS Rule Announcement

AJMC Staff
President Joe Biden will sign an executive order to protect access to the abortion pill and emergency contraception; Governor Gavin Newsom announced California will make low-cost insulin; CMS proposed a rule that would bring major reforms to the accountable care organization program.
Dr Christopher Thompson Discusses GI Innovation Presented at DDW
June 27th 2022

Dr Christopher Thompson Discusses GI Innovation Presented at DDW

Hayden E. Klein Lindsey Mulrooney
Christopher Thompson, MD, MSc, FASGE, FACG, AGAF, FJGES, director of endoscopy and codirector of the Center for Weight Management and Wellness at Brigham & Women’s Hospital, professor of medicine at Harvard Medical School, discusses a session on gastrointestinal (GI) invention at the recent conference, Digestive Disease Week, held May 21-24 in San Diego, California.
Dr Christopher Thompson Discusses Innovative Treatment for Type 2 Diabetes and Obesity
June 24th 2022

Dr Christopher Thompson Discusses Innovative Treatment for Type 2 Diabetes and Obesity

Hayden E. Klein Lindsey Mulrooney
Christopher Thompson, MD, MSc, FASGE, FACG, AGAF, FJGES, director of endoscopy and codirector of the Center for Weight Management and Wellness at Brigham & Women’s Hospital, professor of medicine at Harvard Medical School, discusses duodenal jejunal bypass liner treatment and future innovations in gastroenterology.
What We're Reading
June 20th 2022

What We’re Reading: Period Trackers and Roe v Wade; Medical Debt Burdens; Express Scripts Touts Diabetes Program

AJMC Staff
Data from menstrual tracking apps may be used against people in certain states if Roe v Wade is overturned; 100 million Americans, including 41% of adults, have health care debt; Express Scripts reported results of its program to lower diabetes-related costs.
Child with a doctor
June 17th 2022

Pediatric Liver Disease in Children Linked With a High Risk for T2D, Study Finds

Lindsey Mulrooney
Researchers found significantly higher incidence rates of of type 2 diabetes (T2D) in children with nonalcoholic fatty liver disease compared with other groups.
picture indicating balance
June 16th 2022

Adolescents With T2D Improved Glycemic Control Using Dulaglutide

Allison Inserro
About 3 times as many of the children and teenagers taking dulaglutide had a glycated hemoglobin level of less than 7.0% at 26 weeks compared with those on placebo.
red cross
May 31st 2022

Study Outlines Disparities in ED Use for Patients With Diabetes

Gianna Melillo
Results of a cross-sectional study revealed wide disparities in emergency department (ED) use among patients with diabetes between 2008 and 2017.
vitamin bottle
May 29th 2022

Trial: Vitamin D Supplementation Yielded No Preventive Benefits in T2D

Gianna Melillo
Results of a randomized controlled trial found supplementation with vitamin D among those at risk for type 2 diabetes (T2D) did not prevent onset of the disease.
blood vessel
May 27th 2022

Study: Arterial Stiffness May Be Superior to Hypertension in Predicting Diabetes

Gianna Melillo
Findings of this study showed arterial stiffness is associated with a higher risk of diabetes onset compared with hypertension.
eye ball
May 23rd 2022

Diabetes Drugs Linked With Lower Risks of Open-Angle Glaucoma, AMD

Gianna Melillo
New findings from a prospective cohort study outline associations between diabetes medications and common eye conditions, such as open-angle glaucoma and age-related macular degeneration (AMD).
Marc-Andre Cornier, MD
May 19th 2022

Dr Marc-Andre Cornier Discusses the Future of Research on Weight Loss, Diabetes

Gianna Melillo
Marc-Andre Cornier, MD, professor and director of the Division of Endocrinology, Diabetes and Metabolic Diseases at the Medical University of South Carolina, explains trends he expects to see in upcoming diabetes and weight loss studies.
<1
...
456789101112
...
98>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo